良性前列腺增生症的当代手术和手术管理
Ayodeji E Sotimehin1, Eiftu Haile2, Bradley C Gill3
1Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH sotimea@ccf.org.
Cleveland Clinic journal of medicine
|December 1, 2023
概括
良性前列腺增生症 (BPH) 的手术治疗方法已经显著进步. 目前的BPH干预侧重于个性化的患者护理,将程序与个人需求和特征相匹配,以获得最佳结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 手术创新 在外科创新.
背景情况:
- 良性前列腺增生症 (BPH) 管理已经进化.
- 传统的手术包括通过尿道切除前列腺和简单的前列腺切除术.
- 现在有许多基于办公室和手术室的程序可用.
研究的目的:
- 审查目前BPH的手术和手术治疗方法.
- 突出指南支持的干预措施.
- 强调个性化的BPH治疗选择方法.
主要方法:
- 对当代BPH干预措施的文献综述.
- 分析指南支持的手术和手术选择.
- 讨论影响治疗选择的因素.
主要成果:
- 存在各种各样的BPH干预措施,从传统技术到现代技术.
- 当代的方法优先考虑患者特定的因素.
- 治疗选择是基于前列腺特征,患者偏好和外科医生的专业知识.
结论:
- 个性化医疗是选择最佳BPH干预的关键.
- 由指南支持的程序提供了有效的管理选择.
- BPH治疗的演变为患者提供了定制的解决方案.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
148
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
148
Disorders of the Male Reproductive System
424
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
424
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
188
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
188


